Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study.

Publication Year: 2023

DOI:
10.1097/CCM.0000000000005901

PMCID:
PMC10426778

PMID:
37125800

Journal Information

Full Title: Crit Care Med

Abbreviation: Crit Care Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the code to support this analysis is available at https://doi org/10 5281/zenodo 6448407 ."

Code Sharing
Evidence found in paper:

"Dr. Loomba’s institution received funding from the National Center for Advancing Translational Sciences; she received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest."

Evidence found in paper:

"The work of Dr. Barros was conducted with the support of the Integrated Translational Health Research Institute of Virginia (iTHRIV) Scholars Program. The iTHRIV Scholars Program is supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Numbers UL1TR003015 and KL2TR003016 as well as by the University of Virginia (UVA). This content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or UVA. The work of Dr. Barros was conducted with the support of the Integrated Translational Health Research Institute of Virginia (iTHRIV) Scholars Program. The iTHRIV Scholars Program is supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Numbers UL1TR003015 and KL2TR003016 as well as by the University of Virginia (UVA). This content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or UVA. Dr. Loomba’s institution received funding from the National Center for Advancing Translational Sciences; she received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025